QualityDRIVE™ - embedding Quality by Design (QbD) principles into every phase of your study
Exhibitor
Accelsiors GmbH
At Accelsiors, we redefine clinical trial management through our proprietary QualityDRIVE™ approach, embedding Quality by Design (QbD) principles into every phase of your study. As pioneers in implementing the latest ICH E8(R1) and ICH E6(R3) guidelines, we ensure that quality is not just measured—it is built into the foundation of your clinical research.
By implementing risk-based, scientifically optimized methodologies, we enable sponsors to mitigate challenges proactively, enhance efficiency, and accelerate regulatory approval.
🔹 Meet us at BIO 2025 for a live demonstration of our QbD-driven approach and discover how Accelsiors can transform your clinical trial execution.
🔹 Proactive Planning from the Outset
A successful clinical trial starts long before the first patient is enrolled. Our QualityDRIVE™ methodology ensures that Critical to Quality (CtQ) factors and potential risks are identified before the protocol is finalized.
Design Space Construction Meetings bring together sponsors, vendors, and study teams to develop a quality-focused roadmap, ensuring regulatory alignment, operational efficiency, and scientific rigor.
Risk Assessment & Adaptive Strategies minimize protocol deviations, accelerating study execution without compromising quality.
🔹 Comprehensive Risk Management – A Proactive, Not Reactive, Approach
Beyond traditional monitoring, we integrate continuous risk identification, assessment, control, and review to safeguard data integrity throughout the trial lifecycle.
Advanced Risk-Based Monitoring (RBM) & Centralized Oversight – Ensures early detection of potential challenges, minimizing delays and deviations.
Real-Time Risk Mitigation Strategies – Our cross-functional teams use predictive analytics and AI-powered alerts to anticipate risks before they escalate.
Regulatory Compliance Assurance – Our QbD-driven methodologies align with global regulatory expectations, reducing submission delays and improving approval success rates.
🔹 Data-Driven Oversight with Advanced Technology
Data transparency and real-time monitoring are key to informed decision-making.
WideSCOPE Intelligence™ – AI-Powered Monitoring – Our proprietary analytics platform provides a centralized view of Key Risk Indicators (KRIs) and CtQ factors to enable rapid course correction.
Predictive Modeling & Automated Alerts – Early warning systems detect deviations, allowing proactive resolution before they impact study timelines.
Live Data Visualization – Interactive dashboards offer stakeholders a comprehensive, real-time view of trial performance.
🔹 Efficiency Through Innovation – Technology Meets Strategy
Accelsiors goes beyond traditional trial management by integrating cutting-edge technology with QbD principles to drive efficiency and ensure data reliability.
ACCRACT Risk Assessment Tool – Our proprietary system categorizes risk factors to enhance compliance and accelerate quality outcomes.
AI-Driven Process Optimization – Automates routine quality checks, reducing manual workload while maintaining regulatory integrity.
Streamlined Operational Execution – Adaptive trial design and intelligent risk-mitigation workflows reduce costly delays and improve trial success rates.
🔹 How We Drive Value for You
Faster, More Reliable Study Execution – Risk-based QbD implementation eliminates inefficiencies, accelerates approvals, and minimizes delays.
Proactive Issue Mitigation – Early identification of risks ensures corrective actions are taken before problems arise.
Improved Data Integrity & Compliance – AI-driven monitoring and predictive analytics enhance accuracy and regulatory readiness.
Optimized Resource Utilization – Smart automation and centralized oversight reduce operational burdens and improve cost efficiency.
🔹 Experience QbD Excellence with Accelsiors
At Accelsiors, we don’t just manage clinical trials—we engineer them for success. By embedding Quality by Design principles into every phase, we ensure your research meets and exceeds global regulatory standards.
📍 See our QbD approach in action! Visit us at the German Pavilion at BIO 2025 for an exclusive demonstration and explore how we can help optimize your next clinical trial.
📧 Email: info@accelsiors.com | 🌍 Website: www.accelsiors.com